Legend Biotechcorp Stock Filter Stocks by Fundamentals
LEGN Stock | USD 56.93 1.03 1.84% |
Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.
As of the 28th of March 2024, Cash Per Share is likely to drop to 3.76. Legend | Cash per Share |
Legend Cash per Share Analysis
Current Legend BiotechCorp Cash per Share | 3.76 |
Most of Legend BiotechCorp's fundamental indicators, such as Cash per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Legend Cash per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Legend Stock properly, considering its historical fundamentals such as Cash per Share. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.
Click cells to compare fundamentals
Legend Cash per Share Historical Pattern
Today, most investors in Legend BiotechCorp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Legend BiotechCorp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Legend BiotechCorp cash per share as a starting point in their analysis.
Legend BiotechCorp Cash per Share |
Timeline |
Competition |
Legend Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
All Next | Launch Module |
Legend Fundamentals
Return On Equity | -0.52 | ||||
Return On Asset | -0.17 | ||||
Profit Margin | (1.82) % | ||||
Operating Margin | (1.52) % | ||||
Current Valuation | 9.19 B | ||||
Shares Outstanding | 181.91 M | ||||
Shares Owned By Insiders | 1.28 % | ||||
Shares Owned By Institutions | 48.68 % | ||||
Number Of Shares Shorted | 10.51 M | ||||
Price To Book | 8.13 X | ||||
Price To Sales | 35.57 X | ||||
Revenue | 285.14 M | ||||
Gross Profit | (284.01 M) | ||||
EBITDA | (421.76 M) | ||||
Net Income | (518.25 M) | ||||
Cash And Equivalents | 791.26 M | ||||
Cash Per Share | 5.11 X | ||||
Total Debt | 328.67 M | ||||
Debt To Equity | 0.29 % | ||||
Current Ratio | 3.83 X | ||||
Book Value Per Share | 6.88 X | ||||
Cash Flow From Operations | (384.47 M) | ||||
Short Ratio | 13.11 X | ||||
Earnings Per Share | (2.94) X | ||||
Target Price | 86.56 | ||||
Number Of Employees | 1.8 K | ||||
Beta | 0.039 | ||||
Market Capitalization | 10.14 B | ||||
Total Asset | 1.85 B | ||||
Retained Earnings | (1.48 B) | ||||
Working Capital | 1.28 B | ||||
Z Score | 17.62 | ||||
Net Asset | 1.85 B |
About Legend BiotechCorp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Cash Per Share | 7.43 | 3.76 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.